Published in Brain on June 23, 2004
Neural correlates of reach errors. J Neurosci (2005) 3.40
Basal ganglia contributions to motor control: a vigorous tutor. Curr Opin Neurobiol (2010) 1.73
Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson's disease. J Neurol (2010) 1.57
Velocity control in Parkinson's disease: a quantitative analysis of isochrony in scribbling movements. Exp Brain Res (2009) 1.06
Testing basal ganglia motor functions through reversible inactivations in the posterior internal globus pallidus. J Neurophysiol (2007) 1.05
Visual modulation of proprioceptive reflexes during movement. Brain Res (2008) 0.99
Impaired inhibitory oculomotor control in patients with Parkinson's disease. Exp Brain Res (2006) 0.98
Dopamine replacement therapy does not restore the ability of Parkinsonian patients to make rapid adjustments in motor strategies according to changing sensorimotor contexts. Parkinsonism Relat Disord (2007) 0.95
Motor response programming and movement time in children with heavy prenatal alcohol exposure. Alcohol (2010) 0.95
Visuomotor learning in immersive 3D virtual reality in Parkinson's disease and in aging. Exp Brain Res (2006) 0.95
On-line corrections for visuomotor errors. Exp Brain Res (2009) 0.93
Submovements during pointing movements in Parkinson's disease. Exp Brain Res (2008) 0.84
Spatial-orientation priming impedes rather than facilitates the spontaneous control of hand-retraction speeds in patients with Parkinson's disease. PLoS One (2013) 0.84
Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson's disease. J Commun Disord (2010) 0.83
Two modes of error processing in reaching. Exp Brain Res (2008) 0.82
Postural control anomalies in children with Tourette syndrome. Exp Brain Res (2007) 0.82
The hand's automatic pilot can update visual information while the eye is in motion. Exp Brain Res (2009) 0.81
Dopamine enhances willingness to exert effort for reward in Parkinson's disease. Cortex (2015) 0.80
Interference effects from observed movement in Parkinson's disease. J Mot Behav (2010) 0.79
Altered perceptual sensitivity to kinematic invariants in Parkinson's disease. PLoS One (2012) 0.78
Spatiotemporal dynamics of online motor correction processing revealed by high-density electroencephalography. J Cogn Neurosci (2014) 0.78
Neural Control of Walking in People with Parkinsonism. Physiology (Bethesda) (2016) 0.78
Impact of Parkinson's disease on proprioceptively based on-line movement control. Exp Brain Res (2015) 0.77
Hard and fast rules about the body: contributions of the action stream to judging body space. Exp Brain Res (2011) 0.76
The Importance of Lateral Connections in the Parietal Cortex for Generating Motor Plans. PLoS One (2015) 0.75
Grip force modulation characteristics as a marker for clinical disease progression in individuals with Parkinson disease: case-control study. Phys Ther (2014) 0.75
The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease. Exp Brain Res (2006) 0.75
Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37
Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol (1996) 3.45
Role of the posterior parietal cortex in updating reaching movements to a visual target. Nat Neurosci (1999) 3.39
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06
New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet (1996) 2.20
Normalizing motor-related brain activity: subthalamic nucleus stimulation in Parkinson disease. Neurology (2006) 2.05
Spontaneous intracranial hypotension causing reversible frontotemporal dementia. Neurology (2002) 1.89
Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents. J Biol Chem (1982) 1.83
Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting. J Biol Chem (1998) 1.83
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion. J Biol Chem (1998) 1.45
Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis. Eur Neurol (2008) 1.42
Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol (1999) 1.42
Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc Natl Acad Sci U S A (1993) 1.42
[Familial epilepsy seizure disclosing long QT syndrome]. Rev Neurol (Paris) (1996) 1.39
Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol (2001) 1.32
Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28
Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. J Neurol Neurosurg Psychiatry (2003) 1.23
Molecular analysis of the X11-mLin-2/CASK complex in brain. J Neurosci (1999) 1.22
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology (2008) 1.21
X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J Biol Chem (1998) 1.21
Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol (2002) 1.16
The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion. J Biol Chem (1998) 1.16
Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines. Neuroscience (2010) 1.11
Proprioception does not quickly drift during visual occlusion. Exp Brain Res (2000) 1.10
Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts. J Neurol (2006) 1.10
Involvement of a carbohydrate group in the active site for surface guided reassociation of animal cells. Nature (1973) 1.09
Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases. Biochem J (1983) 1.08
Testing basal ganglia motor functions through reversible inactivations in the posterior internal globus pallidus. J Neurophysiol (2007) 1.05
History of the 'geste antagoniste' sign in cervical dystonia. J Neurol (2012) 1.04
Modulation of amyloid precursor protein metabolism by X11alpha /Mint-1. A deletion analysis of protein-protein interaction domains. J Biol Chem (2000) 1.03
The basal ganglia network mediates the planning of movement amplitude. Eur J Neurosci (2004) 1.02
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J Med Genet (2009) 1.01
Phospholipid-sensitive Ca2+-dependent protein kinase: a major protein phosphorylation system. Mol Cell Endocrinol (1984) 1.01
Cobra polypeptide cytotoxin I and marine worm polypeptide cytotoxin A-IV are potent and selective inhibitors of phospholipid-sensitive Ca2+-dependent protein kinase. FEBS Lett (1983) 1.01
Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder. Neurology (2010) 1.01
Motor imagery of a lateralized sequential task is asymmetrically slowed in hemi-Parkinson's patients. Neuropsychologia (1995) 1.00
Substrate specificity of phospholipid/Ca2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein. J Biol Chem (1985) 0.99
The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase. J Biol Chem (2000) 0.99
Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication? J Neurol Neurosurg Psychiatry (2006) 0.98
Historical underpinnings of the term essential tremor in the late 19th century. Neurology (2008) 0.96
Mirror movements of the non-affected hand in hemiparkinsonian patients: a reflection of ipsilateral motor overactivity? J Neurol Neurosurg Psychiatry (2003) 0.96
Basic protein in brain myelin is phosphorylated by endogenous phospholipid-sensitive Ca2+-dependent protein kinase. J Neurochem (1982) 0.96
Basal ganglia network mediates the control of movement amplitude. Exp Brain Res (2003) 0.95
Use of historical assessment for evaluation of process-based model projections of future environmental change: Lake acidification in the Adirondack mountains, New York, USA. Environ Pollut (1992) 0.95
Inhibition by melittin of phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases. Biochem J (1982) 0.95
Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET study. Neurology (2000) 0.94
Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet (2005) 0.94
X11alpha modulates secretory and endocytic trafficking and metabolism of amyloid precursor protein: mutational analysis of the YENPTY sequence. Neuroscience (2003) 0.93
Activity of neurons in cerebellar-receiving and pallidal-receiving areas of the thalamus of the behaving monkey. J Neurophysiol (1991) 0.92
Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov Disord (2000) 0.91
Poor performance in smooth pursuit and antisaccadic eye-movement tasks in healthy siblings of patients with schizophrenia. Psychiatry Res (2001) 0.90
Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. Arch Neurol (1995) 0.88
Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study. Neurology (2004) 0.88
Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study. J Neurol (2003) 0.87
Motor urgency is mediated by the contralateral cerebellum in Parkinson's disease. J Neurol Neurosurg Psychiatry (2008) 0.87
A chronic arterial and venous cannulation method for freely moving rats. J Neurosci Methods (1985) 0.87
[Juvenile arteriosclerotic leukoencephalopathy: anatomoclinical study of a case]. Rev Neurol (Paris) (1992) 0.87
GABAA receptor pharmacology and subtype mRNA expression in human neuronal NT2-N cells. J Neurosci (1998) 0.87
A possible model for cell-cell recognition via surface macromolecules. Philos Trans R Soc Lond B Biol Sci (1975) 0.86
Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease. Neurophysiol Clin (2001) 0.86
Histiocytic sarcoma of the central nervous system: a challenging diagnosis. QJM (2010) 0.86
[Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications]. Rev Med Interne (2002) 0.85
Reversible Creutzfeldt-Jakob like syndrome induced by lithium plus levodopa treatment. J Neurol Neurosurg Psychiatry (1989) 0.85
The Ohm-Seebeck dispute, Hermann von Helmholtz, and the origins of physiological acoustics. Br J Hist Sci (1977) 0.85
[Ingestion of raw fish: a cause of eosinophilic meningitis caused by Angiostrongylus cantonensis after a trip to Tahiti]. Presse Med (1996) 0.84
Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol. J Neurochem (1999) 0.84
Afterimages of sinusoidal, square-wave and compound gratings. Vision Res (1985) 0.84
A quantitative analysis of pallidal discharge during targeted reaching movement in the monkey. Exp Brain Res (1991) 0.84
Overactivation of primary motor cortex is asymmetrical in hemiparkinsonian patients. Neuroreport (2000) 0.84
Developmental studies of phospholipid-sensitive Ca2+-dependent protein kinase and its substrates and of phosphoprotein phosphatases in rat brain. Proc Natl Acad Sci U S A (1984) 0.83
Screening for DJ-1 mutations in early onset autosomal recessive parkinsonism. Neurology (2003) 0.83
Physiological identification of the human pedunculopontine nucleus. J Neurol Neurosurg Psychiatry (2009) 0.82
The geometry of the human cerebellar vermis. Anat Rec (1968) 0.82
Optic ataxia is not only 'optic': impaired spatial integration of proprioceptive information. Neuroimage (2007) 0.82
Course of valvular strands in patients with stroke: cooperative study with transesophageal echocardiography. Am Heart J (1998) 0.82
Phospholipid-sensitive Ca2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonist. Biochem Pharmacol (1984) 0.81
Pharmacokinetics of apomorphine in parkinsonian patients. Fundam Clin Pharmacol (1993) 0.81
Possible Parkinson's disease revealed by a pure head resting tremor. J Neurol Sci (2009) 0.81
Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease. Neuropsychologia (2003) 0.79
Effects of substance abuse on ventricular and sulcal measures assessed by computerised tomography. Br J Psychiatry (1991) 0.79
Phospholipid-sensitive Ca2+ -dependent protein kinase preferentially phosphorylates serine-115 of bovine myelin basic protein. J Neurochem (1984) 0.79
Pre- and postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN1 and CLN2). Eur J Paediatr Neurol (2001) 0.79
Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery. Lancet (1992) 0.78